26-Dec-2025
No headlines found.
Phreesia Named to The Software Report's "Top 50 Software Companies" for the Fourth Consecutive Year
Business Wire (Thu, 18-Dec 4:05 PM ET)
Phreesia Announces Third Quarter Fiscal 2026 Results and Introduces Fiscal 2027 Outlook
Business Wire (Mon, 8-Dec 4:03 PM ET)
Phreesia's Megan Turco Named to MM+M 40 Under 40
Business Wire (Thu, 4-Dec 4:05 PM ET)
Phreesia Named to the 2025 Deloitte Technology Fast 500
Business Wire (Wed, 19-Nov 4:05 PM ET)
Phreesia Sets Release Date for Fiscal Third Quarter 2026 Results
Business Wire (Mon, 3-Nov 4:04 PM ET)
Phreesia Named to the 2025 Capterra Shortlists for Appointment Reminders and Appointment Scheduling
Business Wire (Wed, 8-Oct 4:05 PM ET)
Phreesia Named to TIME's 2025 List of the World's Top HealthTech Companies
Business Wire (Tue, 30-Sep 4:05 PM ET)
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
Phreesia trades on the NYSE stock market under the symbol PHR.
As of December 26, 2025, PHR stock price climbed to $17.02 with 491,671 million shares trading.
PHR has a beta of 0.87, meaning it tends to be less sensitive to market movements. PHR has a correlation of 0.12 to the broad based SPY ETF.
PHR has a market cap of $1.03 billion. This is considered a Small Cap stock.
Last quarter Phreesia reported $120 million in Revenue and $.07 earnings per share. This beat revenue expectation by $263,084 and missed earnings estimates by -$.17.
In the last 3 years, PHR traded as high as $40.00 and as low as $12.05.
The top ETF exchange traded funds that PHR belongs to (by Net Assets): VTI, IWM, VB, VXF, IWO.
PHR has underperformed the market in the last year with a return of -33.9%, while the SPY ETF gained +16.0%. In the last 3 month period, PHR fell short of the market, returning -27.9%, while SPY returned +4.6%. However, in the most recent 2 weeks PHR has outperformed the stock market by returning +4.7%, while SPY returned +1.5%.
PHR support price is $16.30 and resistance is $17.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PHR shares will trade within this expected range on the day.
